Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurocutaneous Syndromes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01218152
What this trial is testing

Microarray CGH Analysis of Circulating Tumoral Plasma DNA in NF1 Patients With MPNSTs

Who this might be right for
Neurofibromatosis Type 1
KU Leuven 20
Testing effectiveness (Phase 2)Study completedNCT04947124
What this trial is testing

Determine the Safety and Tolerability of 2 Concentrations of QLS-101

Who this might be right for
Sturge-Weber Syndrome (SWS)GlaucomaGlaucoma Congenital+1 more
Qlaris Bio, Inc. 3
Early research (Phase 1)UnknownNCT05531890
What this trial is testing

Comparative Bioavailability of Betamethasone Oral Solution Metered Spray (GTX-102) in Healthy Subjects

Who this might be right for
Ataxia Telangiectasia
Grace Therapeutics Inc. 48
Post-approval studies (Phase 4)Study completedNCT03513757
What this trial is testing

Dexmedetomidine and Propofol for Pediatric MRI Sedation

Who this might be right for
HeadacheTumorSeizure Disorder+4 more
Medical College of Wisconsin 40
Testing effectiveness (Phase 2)Ended earlyNCT02728388
What this trial is testing

Photodynamic Therapy for Benign Dermal Neurofibromas- Phase II

Who this might be right for
NEUROFIBROMATOSIS 1
Donald Basel 30
Testing effectiveness (Phase 2)Study completedNCT01419639
What this trial is testing

Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2

Who this might be right for
Neurofibromatosis Type II
NYU Langone Health 10
Large-scale testing (Phase 3)Active Not RecruitingNCT04924608
What this trial is testing

Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis 1Plexiform Neurofibroma (PN)
AstraZeneca 145
Testing effectiveness (Phase 2)Study completedNCT02332655
What this trial is testing

Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome

Who this might be right for
Sturge-Weber Syndrome
Anne Comi, MD 5
Not applicableStudy completedNCT04561765
What this trial is testing

Innovation in the Treatment of Persistent Pain in Adults With NF1: Implementation of the iCanCope Mobile Application- Clinical Trial

Who this might be right for
Neurofibromatosis 1Chronic Pain
Yale University 122
Large-scale testing (Phase 3)UnknownNCT01730209
What this trial is testing

Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex

Who this might be right for
Tuberous Sclerosis ComplexTSC Related Cognitive DisabilityTSC Related Autism+1 more
Erasmus Medical Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT06081348
What this trial is testing

Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders

Who this might be right for
Neurodevelopmental DisordersAutismAutism Spectrum Disorder+14 more
Holland Bloorview Kids Rehabilitation Hospital 130
Testing effectiveness (Phase 2)Study completedNCT03962114
What this trial is testing

Effects of Vitamin B3 in Patients With Ataxia Telangiectasia

Who this might be right for
Ataxia TelangiectasiaATM Gene Mutation
Radboud University Medical Center 24
Large-scale testing (Phase 3)Ended earlyNCT02256124
What this trial is testing

Effect of Lamotrigine on Cognition in NF1

Who this might be right for
Neurofibromatosis Type 1
Erasmus Medical Center 41
Very early researchStudy completedNCT01275586
What this trial is testing

Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas

Who this might be right for
NeurofibromatosisNF1Neurofibromas
Indiana University 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT01362803
What this trial is testing

AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors

Who this might be right for
Neurofibromatosis 1Neurofibromatosis Type 1NF1+1 more
National Cancer Institute (NCI) 99
Testing effectiveness (Phase 2)Ended earlyNCT01266070
What this trial is testing

TKI 258 in Von Hippel-Lindau Syndrome (VHL)

Who this might be right for
Von Hippel-Lindau Syndrome
M.D. Anderson Cancer Center 6
Not applicableNo Longer AvailableNCT02589912
What this trial is testing

Compassionate Use Arm - ABI541 ABI for 10 NF2 Patients

Who this might be right for
Neurofibromatosis Type 2Severe Profound Sensorineural Hearing Loss
Massachusetts Eye and Ear Infirmary
Testing effectiveness (Phase 2)Study completedNCT02304367
What this trial is testing

Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)

Who this might be right for
Tumor Induced Osteomalacia (TIO)Epidermal Nevus Syndrome (ENS)
Kyowa Kirin, Inc. 17
Testing effectiveness (Phase 2)Study completedNCT01526356
What this trial is testing

Topical Rapamycin to Erase Angiofibromas in TSC

Who this might be right for
AngiofibromasTuberous Sclerosis
The University of Texas Health Science Center, Houston 179
Not applicableEnrolling By InvitationNCT06879665
What this trial is testing

TANDem-2: Closing the Gap to Interventions for TAND

Who this might be right for
Adult Caregivers of Individuals With TSCTuberous Sclerosis Complex (TSC)
Vrije Universiteit Brussel 30
Next Page